Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide,...

American Journal of Clinical Oncology 2020 / 06 Vol. 43; Iss. 6

Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas

Hammer, Kathryn J., Copeland, Vanessa C., Loggers, Elizabeth T., Pollack, Seth M., Wagner, Michael J., Cranmer, Lee D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
43
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/coc.0000000000000690
Date:
June, 2020
File:
PDF, 183 KB
2020
Conversion to is in progress
Conversion to is failed